Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Deal Watch, M&A: Warp Drive And Its Partnerships Acquired By Revolution

Executive Summary

Once expected to be absorbed by Sanofi, US biotech Warp Drive Bio now will become part of California’s Revolution Medicines in a stock transaction. Sosei elects against its option to acquire MiNA Therapeutics; MeiraGTX follows its June IPO with takeout of Vector Neurosciences. Other recent mergers and acquisitions... 


Related Content

MeiraGTx Signs J&J To Develop Gene Therapies For Rare Retinal Diseases
CDMO Space In Focus As Piramal Mulls Sale
Novartis Tunes Into Radiopharmaceuticals With Endocyte Buy
Mundipharma Satisfies Appetite For Piece Of $4.5bn Pegfilgrastim Pie With Cinfa Biotech Buy
ASLAN, Sosei Pipeline Assets Hit By Development Delays
IPO Update: Returns Rebound As June Sees Its First New Biopharma Offering
Roche Goes Back To Nature With Warp Drive Antibiotic Pact
Sosei Backs RNA Activation Through Sizeable Equity And Option Deal
Sanofi Extends, Revamps Discovery Pact With Warp Drive
In Warp Drive Deal, VCs Have A Potential Buyer – And Can Force A Sale


Related Companies

Related Deals




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts